0. DOCID:21976 SCORE: 0.00468299094578138
DOCNO: 8066932
OWNER: NLM
STATUS: MEDLINE
DESCRIPTOR: Esophagus
DESCRIPTOR: Foreign Bodies
AUTHOR: L T Hansen LT
AUTHOR: A Grøntved A
AFFILIATION: Odense Universitetshospital, øre-, naese- og halsafdeling F.
PUBTYPE: Journal Article
JOURNALTITLE: Ugeskrift for laeger.
COUNTRY: DENMARK
TITLE: [Foreign body in the esophagus]
PUBDATE: 19940701
A ten year retrospective survey of 346 cases of oesophageal foreign bodies is reported. Although coins were the most frequent foreign bodies in the pediatry group, meat was the most common offender in the material taken as a whole. Rigid oesophagoscopy in general anaesthesia was performed on 312 patients. A foreign body was removed in 281 cases (90%). Only one case of oesophageal cancer was discovered. The risk of iatrogenic perforation of the oesophagus was greatest in old patients who had a lump of meat stuck in the distal third of the oesophagus.

1. DOCID:21928 SCORE: 0.00468298948267234
DOCNO: 9051048
OWNER: NLM
STATUS: MEDLINE
DESCRIPTOR: Endoscopy
DESCRIPTOR: Magnetic Resonance Imaging
QUALIFIER: diagnosis
QUALIFIER: diagnosis
AUTHOR: D R Feldman DR
AUTHOR: D P Kulling DP
AUTHOR: R H Hawes RH
AUTHOR: C L Kay CL
AUTHOR: V R Muckenfuss VR
AUTHOR: P B Cotton PB
AUTHOR: D E Bohning DE
AUTHOR: J W Young JW
AFFILIATION: Department of Diagnostic Radiology, Medical University of South Carolina, Charleston, SC 29425, USA.
PUBTYPE: Journal Article
JOURNALTITLE: Radiology.
COUNTRY: UNITED STATES
TITLE: MR endoscopy: preliminary experience in human trials.
PUBDATE: 19970301
The authors performed local staging of esophageal and rectal cancer (without pathologic correlation) with use of a nonferromagnetic magnetic resonance (MR) endoscope with a 3-cm-long receive-only coil embedded in its tip in 16 patients (eight with esophageal cancer and eight with anorectal cancer). Results with spin-echo sequences were optimal in all cases [corrected].

2. DOCID:25859 SCORE: 0.00388420247229774
DOCNO: 12113028
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: classification
QUALIFIER: drug therapy
QUALIFIER: methods
QUALIFIER: classification
QUALIFIER: drug therapy
QUALIFIER: methods
AUTHOR: M J Edelman MJ
AFFILIATION: University of Maryland, Greenebaum Cancer Center, Baltimore, Maryland, USA. medelman@umm.edu
PUBTYPE: Journal Article
PUBTYPE: Review
JOURNALTITLE: Expert review of anticancer therapy.
COUNTRY: England
TITLE: Neoadjuvant chemotherapy in early-stage non-small cell lung cancer.
PUBDATE: 20010801
Of the patients that undergo complete resection of early-stage non-small cell lung cancer (NSCLC), 30-60% will die. Postoperative adjuvant chemotherapy has yet to demonstrate an unequivocal benefit and there are significant difficulties in administering postoperative chemotherapy to patients with the significant comorbidities found in NSCLC. Currently, several trials are evaluating the role of preoperative chemotherapy in stage I and II NSCLC. This paper reviews the rationale for this approach and potential future developments.

3. DOCID:25851 SCORE: 0.00388420233620071
DOCNO: 9555428
OWNER: NLM
STATUS: MEDLINE
DESCRIPTOR: Home Care Services
QUALIFIER: methods
QUALIFIER: nursing
QUALIFIER: methods
AUTHOR: R Van Gerpen R
PUBTYPE: Journal Article
JOURNALTITLE: ONS news / Oncology Nursing Society.
COUNTRY: UNITED STATES
TITLE: Homecare nurses face unique challenges in caring for patients with cancer.
PUBDATE: 19980201
Oncology care is going home. The changes in health care that have occurred during the past decade have significantly impacted the growth of home care. Factors that have contributed to this growth include prospective payments for hospital services to Medicare patients leading to a decreased length of stay, advances in the development of equipment for providing high-tech treatments in the home, changes in reimbursement from fee-for-service to managed care and capitation, an aging population, and improved survival rates for patients with chronic illnesses, including cancer.

4. DOCID:27875 SCORE: 0.00382758928799462
DOCNO: 9752329
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: physiology
QUALIFIER: physiology
QUALIFIER: immunology
QUALIFIER: physiology
AUTHOR: A Berger A
AUTHOR: B Piqueras B
AUTHOR: F Pages F
AUTHOR: E Tartour E
AUTHOR: P H Cugnenc PH
AUTHOR: W H Fridman WH
AFFILIATION: Service de chirurgie générale, digestive et oncologique, Hôpital Laennec, Paris.
PUBTYPE: Journal Article
PUBTYPE: Review
JOURNALTITLE: Bulletin du cancer.
COUNTRY: FRANCE
TITLE: [Fas, fas ligand, immune tolerance, and cancer: implications in cancer of the colon]
PUBDATE: 19980201
Fas and Fas ligand (FasL) are implicated in programmed cell death or apoptosis. In the immunological field, they are particularly important in auto-immunity, graft rejection and anti-tumoral response. Fas ligand expression on thymocytes, activated T lymphocytes, and in sites of immune privilege, suggests the importance of Fas/FasL interactions in negative control of the immune response. The recent description of FasL expression by tumoral cells, represents a new mechanism of immune escape for different cancer, and has been well studied in colon adenocarcinoma.

5. DOCID:27800 SCORE: 0.003827588820948
DOCNO: 10967793
OWNER: NLM
STATUS: MEDLINE
DESCRIPTOR: Aromatase Inhibitors
DESCRIPTOR: Oncologic Nursing
QUALIFIER: drug therapy
QUALIFIER: therapeutic use
AUTHOR: A O Cloutier AO
AFFILIATION: Shering Oncology Biotech, Kenilworth, NJ, USA.
PUBTYPE: Journal Article
PUBTYPE: Review
JOURNALTITLE: Seminars in oncology nursing.
COUNTRY: UNITED STATES
TITLE: Advanced breast cancer: recent developments in hormonal therapy.
PUBDATE: 20000801
OBJECTIVES: To review recent developments in hormonal therapy for metastatic breast cancer. DATA SOURCES: Published books and articles. CONCLUSIONS: Newer hormonal agents are offering women alternatives for sequential therapy of metastatic disease that provide benefit with less risk. IMPLICATIONS FOR NURSING PRACTICE: A thorough understanding of the relationship between hormonal influences and breast cancer will assist nurses to better appreciate the variety of agents now available and their specific indications, outcomes, and effects. Common side effects include weight gain, hot flashes, nausea, and skin and vaginal changes. Nursing efforts focus on the areas of body image disturbance, side effect management, and fostering healthy relationships.

6. DOCID:25868 SCORE: 0.00306369715937712
DOCNO: 11787295
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: standards
QUALIFIER: methods
QUALIFIER: standards
AUTHOR: A Yoshizawa A
AUTHOR: Y Gyouda Y
AUTHOR: T Ishiguro T
AUTHOR: S Yoshida S
AUTHOR: T Yoshizawa T
AUTHOR: I Narita I
AUTHOR: M Tsuruta M
AUTHOR: Y Fukumoto Y
AFFILIATION: Dept. of Home Care, Kaname-cho Hospital.
PUBTYPE: Journal Article
JOURNALTITLE: Gan to kagaku ryoho. Cancer & chemotherapy.
COUNTRY: Japan
TITLE: [Indication of home oxygen therapy for terminal cancer patients--comparison with present standards--as the result from investigation of our patients and questionnaire survey to home care doctors]
PUBDATE: 20011201
As the result of the observation of our patients and a questionnaire answered by home care doctors, we think it is necessary to establish new standards for home oxygen therapy, based on the characteristics of terminal cancer patients and to put great emphasis on the QOL of patients.

7. DOCID:19775 SCORE: 0.00301219595983401
DOCNO: 1287609
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: epidemiology
QUALIFIER: epidemiology
AUTHOR: K Sein K
AUTHOR: K K Maung KK
AUTHOR: T H Aung TH
AFFILIATION: Department of Dental Health, Institute of Dental Medicine, Yangon, Myaumar.
PUBTYPE: Journal Article
JOURNALTITLE: Odonto-stomatologie tropicale = Tropical dental journal.
COUNTRY: SENEGAL
TITLE: An epidemiologic study of 70 oral cancer cases at the Institute of Dental Medicine, Yangon, Myanmar, 1985-1988.
PUBDATE: 19920301
This study shows that in Myanmar, South-East Asia, the prevalence of oral cancers is a serious fact as they rank fifth among all cancers being known there. On the 70 oral cancer cases reported at the Institute of Dental Medicine, Yangon, the findings stressed that most patients, male or female, came from the metropolitan division (Yangon), had smoking and chewing habits. Also most of these patients came to hospital only at the severe and late stage. It confirms us in our opinion that early diagnosis and prompt treatment are a necessity.

8. DOCID:22450 SCORE: 0.00294926563094787
DOCNO: 8922214
OWNER: NLM
STATUS: MEDLINE
DESCRIPTOR: Perioperative Nursing
QUALIFIER: nursing
AUTHOR: D R McEwen DR
AUTHOR: M M Sanchez MM
AUTHOR: A Rosario A
AUTHOR: W E Allen WE
AFFILIATION: South Texas Veterans Health Care System, Audie L. Murphy Division, San Antonio, USA.
PUBTYPE: Case Reports
PUBTYPE: Journal Article
PUBTYPE: Review
JOURNALTITLE: AORN journal.
COUNTRY: UNITED STATES
TITLE: Managing patients with pancreatic cancer.
PUBDATE: 19961101
The diagnosis of pancreatic cancer is devastating for patients and family members because of the high morbidity and mortality rates associated with the disease. Regardless of the stages of their illnesses or the treatments they receive, only 3% of patients diagnosed with pancreatic cancer survive five years or more after diagnosis. Compassionate, knowledgeable, supportive nursing care is necessary throughout all stages of pancreatic cancer. This article provides perioperative nurses with information about the diagnosis, treatment, and palliative care for patients diagnosed with pancreatic cancer.

9. DOCID:27163 SCORE: 0.00292115875936772
DOCNO: 10884619
OWNER: NLM
STATUS: MEDLINE
DESCRIPTOR: Bifidobacterium
DESCRIPTOR: Lactobacillus
QUALIFIER: prevention & control
QUALIFIER: therapeutic use
AUTHOR: K Hirayama K
AUTHOR: J Rafter J
AFFILIATION: Department of Medical Nutrition, Karolinska Institute, NOVUM, S-141 86, Huddinge, Sweden.
PUBTYPE: Journal Article
PUBTYPE: Review
JOURNALTITLE: Microbes and infection / Institut Pasteur.
COUNTRY: FRANCE
TITLE: The role of probiotic bacteria in cancer prevention.
PUBDATE: 20000501
Colorectal cancer is one of the most important causes of cancer morbidity and mortality in western countries [1]. A myriad of healthful effects have been attributed to the probiotic lactic acid bacteria; perhaps the most controversial remains that of anticancer activity. There is no direct experimental evidence for cancer suppression in humans as a result of consumption of lactic cultures in fermented or unfermented dairy products. However, there is a wealth of indirect evidence, based largely on laboratory studies, in the literature and this will be summarised in the present paper.

10. DOCID:23202 SCORE: 0.0028969758153263
DOCNO: 8052876
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: therapeutic use
QUALIFIER: drug therapy
QUALIFIER: administration & dosage
QUALIFIER: drug therapy
AUTHOR: N van Zandwijk N
AUTHOR: O Dalesio O
AFFILIATION: Department of Pulmonary Oncology, The Netherlands Cancer Institute, Amsterdam.
PUBTYPE: Journal Article
PUBTYPE: Review
JOURNALTITLE: Seminars in oncology.
COUNTRY: UNITED STATES
TITLE: Platinum-based chemotherapy in non-small cell lung cancer: the experience of the European Organization for the Research and Treatment of Cancer.
PUBDATE: 19940601
The history of chemotherapy for non-small cell lung carcinoma is one of very slow progress. Consequently, the categories of patients who will ultimately benefit from this modality are still debated. Recent European Organization for Research and Treatment of Cancer studies show that there is less concern about the importance of platinum as an ingredient of combination regimens or as an adjunct to radiotherapy. The presence of cisplatin is related to better response and survival in patients with locoregional and distant metastatic disease.

11. DOCID:23135 SCORE: 0.00289697180072711
DOCNO: 9052666
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: diagnosis
QUALIFIER: diagnosis
QUALIFIER: pathology
QUALIFIER: pathology
AUTHOR: J D Browne JD
AFFILIATION: Department of Otolaryngology, Bowman Gray School of Medicine, Wake Forest University, Winston-Salem, North Carolina 27157, USA.
PUBTYPE: Journal Article
PUBTYPE: Review
JOURNALTITLE: Otolaryngologic clinics of North America.
COUNTRY: UNITED STATES
TITLE: Management of nonepidermoid cancer of the larynx.
PUBDATE: 19970401
Nonepidermoid cancer of the larynx represents an extremely diverse group of diseases with differing prognoses and rationales of management. With the lack of specificity in symptoms and physical findings, proper and expeditious lesion characterization is therefore dependent on a high index of suspicion by the clinician and accurate consulting histopathology. These neoplasms can be grouped according to cells with secretory, connective tissue, lymphoreticular, or metastatic origins. Based upon this framework, this article discusses the unique aspects of these various diseases that can lead to their diagnosis, along with consideration of management options and prognostic variables.

12. DOCID:26706 SCORE: 0.00286790081896959
DOCNO: 9676499
OWNER: NLM
STATUS: MEDLINE
DESCRIPTOR: Sick Role
QUALIFIER: diagnosis
QUALIFIER: diagnosis
QUALIFIER: psychology
QUALIFIER: statistics & numerical data
AUTHOR: R A Schneider RA
AFFILIATION: Buena Vista University, Storm Lake, IA 50588, USA. bschneid@pionet.net
PUBTYPE: Journal Article
JOURNALTITLE: Psychological reports.
COUNTRY: UNITED STATES
TITLE: Concurrent validity of the Beck Depression Inventory and the multidimensional fatigue inventory-20 in assessing fatigue among cancer patients.
PUBDATE: 19980601
Cancer patients experience both fatigue and depression while undergoing treatment for their disease. A number of authors have conceptualized such depression among this populations as secondary to fatigue. This study of 54 patients was done to test the concurrent validity of two inventories. Scores on the five subscales of the 20-item Multidimensional Fatigue Inventory were correlated with those on the 21-item Beck Depression Inventory. Moderate correlations are reported and the potential usefulness of the Multidimensional Fatigue Inventory is discussed.

13. DOCID:22343 SCORE: 0.00284435685770307
DOCNO: 9404833
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: chemically induced
QUALIFIER: adverse effects
QUALIFIER: chemically induced
QUALIFIER: complications
AUTHOR: M A Golden MA
AUTHOR: D J Vaughn DJ
AUTHOR: G W Crooks GW
AUTHOR: G A Holland GA
AUTHOR: J E Bavaria JE
AFFILIATION: Department of Surgery, The Hospital of the University of Pennsylvania, Philadelphia 19104, USA.
PUBTYPE: Case Reports
PUBTYPE: Journal Article
PUBTYPE: Review
JOURNALTITLE: Angiology.
COUNTRY: UNITED STATES
TITLE: Aortic dissection in a patient receiving chemotherapy for Hodgkin's disease--a case report.
PUBDATE: 19971201
Cancer chemotherapy is associated with a wide range of vascular toxicities, which may be related to endothelial cell damage by these agents. The authors describe a patient with Hodgkin's disease who developed an atypical aortic dissection while receiving MOPP/ABV chemotherapy (nitrogen mustard, vincristine, procarbazine, prednisone, doxorubicin, bleomycin, and vinblastine). They would place aortic dissection on the list of potential vascular complications associated with antineoplastic agents.

14. DOCID:23987 SCORE: 0.00282484671653424
DOCNO: 9001760
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: therapeutic use
QUALIFIER: drug therapy
QUALIFIER: drug therapy
AUTHOR: F A Shepherd FA
AFFILIATION: Department of Medicine, Toronto Hospital, University of Toronto, Ontario, Canada.
PUBTYPE: Journal Article
PUBTYPE: Review
JOURNALTITLE: Chest surgery clinics of North America.
COUNTRY: UNITED STATES
TITLE: The role of chemotherapy in the treatment of small cell lung cancer.
PUBDATE: 19970201
Because small cell lung cancer (SCLC) is a systemic malignancy, chemotherapy is the mainstay treatment for patients with all stages of this tumor. Many chemotherapeutic agents have activity against SCLC, and when combined in three- or four-drug regimens, they produce a response in 75% to 90% of patients. Median survival times for patients with limited disease range from 14 to 16 months, and a small proportion may be cured. For extensive stage patients, median survival is usually less than 1 year; 2 year disease-free survival is uncommon. Current research is focusing on ways to increase the dose intensity of chemotherapy delivery.